Phase
Condition
Sickle Cell Disease
Focal Segmental Glomerulosclerosis
Nephropathy
Treatment
iohexol GFR
Clinical Study ID
Ages 5-50 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
SCA patients (HbSS and SB0 thalassemia)
Age: 5.0-50.0 at enrollment
Exclusion
Exclusion Criteria:
Recent SCA complication associated with hospitalization (within 30 days) or ED visit (within 14 days)
Current AKI defined as >0.3mg/g increase in SCr from prior visit
Known history of anaphylaxis with contrast agent or known pregnancy
Study Design
Study Description
Connect with a study center
University of Alabama at Birmingham
Birmingham, Alabama 35223
United StatesActive - Recruiting
University of Illinois Chicage
Chicago, Illinois 60612
United StatesActive - Recruiting
St Jude Childrens Research Hospital
Memphis, Tennessee 38106
United StatesActive - Recruiting
University of Tennessee Health Science Center
Memphis, Tennessee 38163
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.